Novartis has paused a trial of its Zolgensma gene therapy that treats spinal muscular atrophy, the Wall Street Journal reports.
The New York Times reports on CRISPR's potential as an antibiotic.
Reuters reports that Scott Gottlieb, the former Food and Drug Administration commissioner, plans to focus in part on new antibiotics in his venture capital role.
In Genome Biology this week: effect of structural variants in cancer, comparison of human and primate gut microbiomes, and more.
The North Jersey Record looks into genetic testing to guide cancer treatment, particularly fluorouracil.
Time magazine discusses Biogen's move to resurrect its Alzheimer's disease drug.
The Guardian reports that birds' eggs may be darker in cooler regions because of how they retain heat.
In PNAS this week: analysis of extensively drug-resistant Mycobacterium tuberculosis strain, regulation of obesity-linked gene, and more.
Science reports a German university found evidence that a researcher who developed a controversial blood test for breast cancer committed misconduct.
In an op-ed at the Washington Post, the University of Pennsylvania's Ravi Parikh writes that research conducted by for-profit companies shouldn't be overlooked.
Wired reviews a new cat DNA testing service, but notes cats are less studied than dogs, affecting how much data can be provided.
In PLOS this week: RAPGEF6 gene insertion linked to laryngeal paralysis in Miniature Bull Terriers, colorectal cancer risk among Zimbabweans, and more.
The US National Institutes of Health says 44 chimpanzees are too frail to move to a retirement sanctuary.
Two researchers have uncovered ways that users of genetic genealogy sites could be susceptible to "genetic hacking."
NPR reports that visa issues have prevented a number of researchers from attending this year's Society for Neuroscience meeting in the US.
In Science this week: a review says lifestyles of industrialized societies may be threatening needed gut microbial communities, and more.
Law enforcement officials say that changes to genetic genealogy databases have limited their ability to track down some suspects, NBC News reports.
Mice whose gut microbiomes have been disrupted are unable to overcome fear conditioning, New Scientist says.
A new study finds women are less likely than men to write invited commentaries in medical journals.
In Nature this week: pan-cancer study of metastatic solid tumors, genetic variants associated with range of traits cluster by region in the UK, and more.
Seven individuals have been named to the President's Council of Advisors on Science and Technology, ScienceInsider reports.
Retraction Watch reports that a series of tweets led to expression of concern for a PLOS Genetics paper, a move the paper's authors disagree with.
Researchers have sequenced pumas from North and South America to enable better identification of inbreeding, Cosmos magazine reports.
In Nucleic Acids Research this week: ways to find cell death or proliferation signatures, Han Chinese population genome database, and more.
Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.